Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Dec. 31, 2020	Jun. 30, 2020
Current assets
Cash and cash equivalents	$ 732	$ 871
Receivables, net	616	648
Inventories, net	609	454
Prepaid expenses and other current assets	146	47
Total current assets	2,103	2,020
Property, plant and equipment, net of accumulated depreciation and amortization of $2,319 and $2,224, respectively	1,221	1,103
Operating lease right-of-use assets	322	291
Goodwill	1,803	1,577
Trademarks, net	788	785
Other intangible assets, net	261	109
Other assets	357	328
Total assets	6,855	6,213
Current liabilities
Current maturities of long-term debt	300	0
Current operating lease liabilities	61	64
Accounts payable and accrued liabilities	1,377	1,329
Income taxes payable	0	25
Total current liabilities	1,738	1,418
Long-term debt	2,483	2,780
Long-term operating lease liabilities	313	278
Other liabilities	813	767
Deferred income taxes	128	62
Total liabilities	5,475	5,305
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 and 158,741,461 shares issued as of December 31, 2020 and June 30, 2020, respectively; and 125,724,327 and 126,198,606 shares outstanding as of December 31, 2020 and June 30, 2020, respectively	131	159
Additional paid-in capital	1,176	1,137
Retained earnings	1,302	3,567
Treasury shares, at cost: 5,017,134 and 32,542,855 shares as of December 31, 2020 and June 30, 2020, respectively	(850)	(3,315)
Accumulated other comprehensive net (loss) income	(575)	(640)
Total Clorox stockholders’ equity	1,184	908
Noncontrolling interests	196	0
Total stockholders’ equity	1,380	908
Total liabilities and stockholders’ equity	$ 6,855	$ 6,213
Common stock, shares issued (in shares)	130,741,461	158,741,461